REGENXBIO Inc.
USD12.02
+0.19 (+1.59%)
CEO
Curran Simpson
IPO Date
2015-09-17
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$11.85
Prev. Close
$11.83
Day Low
$11.70
Day High
$12.24
52W Low
$5.46
52W High
$16.19
Market Cap
$0.62B
Volume
0.45M
| -1.7 |
| 31 Dec 2023 | FY | 58.8% | -292.0% | -84.5% | -45.9% | 0.29 | 2.57 | -3.0 |
| 31 Dec 2022 | FY | 51.6% | -248.7% | -54.3% | -33.6% | 0.18 | 3.19 | -3.5 |
| 31 Dec 2021 | FY | 89.0% | 27.2% | 16.7% | 11.5% | 0.11 | 3.98 | 10.9 |
| 31 Dec 2020 | FY | 76.9% | -72.0% | -29.5% | -15.7% | 0.19 | 6.52 | -15.2 |
| 31 Dec 2019 | FY | 76.6% | -268.9% | -21.0% | -19.0% | 0.03 | 10.25 | -15.9 |
| 31 Dec 2018 | FY | 95.6% | 45.7% | 19.6% | 18.4% | 0.01 | 15.24 | 15.4 |
| 31 Dec 2017 | FY | 83.6% | -704.0% | -40.0% | -36.8% | 0.00 | 11.64 | -13.6 |
| 31 Dec 2016 | FY | 79.1% | -1372.1% | -38.9% | -36.5% | 0.00 | 9.66 | -7.8 |
| -2.8 |
| 30 Sept 2025 | Q3 | -107.9% | -208.3% | -38.4% | -11.8% | 1.66 | 2.66 | -2.0 |
| 30 Jun 2025 | Q2 | 57.3% | -331.8% | -33.2% | -12.2% | 0.36 | 3.13 | -1.5 |
| 31 Mar 2025 | Q1 | 96.1% | 6.8% | 2.2% | 1.2% | 0.29 | 2.93 | 15.1 |
| 31 Dec 2024 | Q4 | 70.2% | -241.3% | -19.7% | -11.0% | 0.32 | 2.69 | -1.9 |
| 30 Sept 2024 | Q3 | 48.8% | -246.3% | -19.8% | -11.5% | 0.28 | 3.05 | -2.2 |
| 30 Jun 2024 | Q2 | 34.4% | -237.7% | -15.2% | -9.3% | 0.46 | 3.53 | -2.6 |
| 31 Mar 2024 | Q1 | 45.8% | -405.4% | -16.2% | -10.1% | 0.44 | 3.59 | -3.9 |
| 31 Dec 2023 | Q4 | 29.9% | -283.1% | -20.2% | -11.0% | 0.29 | 2.57 | -3.1 |